Sapu-003

N/A

Report date: 2026/01/29 20:00:06
NME

Base Information

Drug NameSapu-003
Drug Alias NameSapu003Sapu-003
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerCarcinoma, Renal CellCarcinoma, Hepatocellular +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSapu Nano (US) Llc
China Registration ClassN/A

Develop Information

Active CompaniesSapu Nano (US) Llc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerCarcinoma, Renal CellCarcinoma, Hepatocellular +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A